• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Glomerular Diseases in Patients with Diabetes Mellitus: An Underappreciated Epidemic.糖尿病患者的肾小球疾病：一种未得到充分重视的流行病。
Kidney360. 2020 Feb 6;1(3):220-222. doi: 10.34067/KID.0000792019. eCollection 2020 Mar 26.
2
Diabetes mellitus as a cause or comorbidity of chronic kidney disease and its outcomes: the Gonryo study.糖尿病作为慢性肾脏病的病因或合并症及其预后：Gonryo研究
Clin Exp Nephrol. 2018 Apr;22(2):328-336. doi: 10.1007/s10157-017-1451-4. Epub 2017 Jul 27.
3
Diabetes and diabetic nephropathy - a worldwide problem.糖尿病及糖尿病肾病——一个全球性问题。
Acta Diabetol. 2004 Mar;41 Suppl 1:S3-5. doi: 10.1007/s00592-004-0130-6.
4
Diabetic Nephropathy Following Posttransplant Diabetes Mellitus.移植后糖尿病所致的糖尿病肾病
Exp Clin Transplant. 2019 Apr;17(2):138-146. doi: 10.6002/ect.2018.0157.
5
Clinical predictors differentiating non-diabetic renal diseases from diabetic nephropathy in a large population of type 2 diabetes patients.在大量2型糖尿病患者中区分非糖尿病性肾脏疾病与糖尿病肾病的临床预测因素。
Diabetes Res Clin Pract. 2016 Nov;121:112-118. doi: 10.1016/j.diabres.2016.09.005. Epub 2016 Sep 21.
6
The apparent epidemic of diabetes and renal disease among American Indians.美国印第安人中明显的糖尿病和肾病流行情况。
Nephrol News Issues. 1989 Aug;3(8):29, 32.
7
[Clinical and social impact of the diabetes mellitus epidemic].[糖尿病流行的临床与社会影响]
Nefrologia. 2008;28(3):245-8.
8
[Diabetes mellitus and diabetic nephropathy. How big is the problem?].[糖尿病与糖尿病肾病。问题有多严重？]
Nefrologia. 2001;21 Suppl 3:4-11.
9
Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury.小鼠2型糖尿病肾病中的巨噬细胞：与糖尿病状态及进行性肾损伤的相关性
Kidney Int. 2004 Jan;65(1):116-28. doi: 10.1111/j.1523-1755.2004.00367.x.
10
Differences in susceptibility to develop parameters of diabetic nephropathy in four mouse strains with type 1 diabetes.四种 1 型糖尿病小鼠品系发生糖尿病肾病参数易感性的差异。
Am J Physiol Renal Physiol. 2014 May 15;306(10):F1171-8. doi: 10.1152/ajprenal.00595.2013. Epub 2014 Mar 12.

引用本文的文献

1
Potential Role of Mineralocorticoid Receptor Antagonists in Nondiabetic Chronic Kidney Disease and Glomerular Disease.醛固酮受体拮抗剂在非糖尿病慢性肾脏病和肾小球疾病中的潜在作用。
Clin J Am Soc Nephrol. 2024 Nov 1;19(11):1499-1512. doi: 10.2215/CJN.0000000000000540. Epub 2024 Jul 22.
2
Screening candidate diagnostic biomarkers for diabetic kidney disease.筛选糖尿病肾病的候选诊断生物标志物。
J Clin Lab Anal. 2024 Feb;38(3):e25000. doi: 10.1002/jcla.25000. Epub 2024 Feb 1.
3
Multifaceted relationship between diabetes and kidney diseases: Beyond diabetes.糖尿病与肾脏疾病之间的多方面关系：超越糖尿病本身。
World J Diabetes. 2023 Oct 15;14(10):1450-1462. doi: 10.4239/wjd.v14.i10.1450.
4
CureGN-Diabetes Study: Rationale, Design, and Methods of a Prospective Observational Study of Glomerular Disease Patients with Diabetes.CureGN-糖尿病研究：糖尿病肾小球疾病患者前瞻性观察性研究的原理、设计与方法
Glomerular Dis. 2023 Jun 26;3(1):155-164. doi: 10.1159/000531679. eCollection 2023 Jan-Dec.
5
Impact of Diabetic Lesions on Pathology, Treatment, and Outcomes of Glomerular Diseases.糖尿病病变对肾小球疾病的病理、治疗和结局的影响。
Kidney360. 2023 Oct 1;4(10):1445-1453. doi: 10.34067/KID.0000000000000247. Epub 2023 Aug 29.
6
Glomerular Diseases in Diabetic Patients: Implications for Diagnosis and Management.糖尿病患者的肾小球疾病：对诊断和管理的启示
J Clin Med. 2021 Apr 24;10(9):1855. doi: 10.3390/jcm10091855.
7
Targeted Next-Generation Sequencing Identifies Pathogenic Variants in Diabetic Kidney Disease.靶向下一代测序鉴定糖尿病肾病的致病性变异。
Am J Nephrol. 2021;52(3):239-249. doi: 10.1159/000514578. Epub 2021 Mar 26.

本文引用的文献

1
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy.利妥昔单抗或环孢素治疗膜性肾病。
N Engl J Med. 2019 Jul 4;381(1):36-46. doi: 10.1056/NEJMoa1814427.
2
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.卡格列净与 2 型糖尿病和肾病患者的肾脏结局。
N Engl J Med. 2019 Jun 13;380(24):2295-2306. doi: 10.1056/NEJMoa1811744. Epub 2019 Apr 14.
3
CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease. CureGN 研究背景、设计和方法：建立肾小球疾病的大型前瞻性观察研究。
Am J Kidney Dis. 2019 Feb;73(2):218-229. doi: 10.1053/j.ajkd.2018.07.020. Epub 2018 Nov 9.
4
DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS.DUET 研究：一项评估 Sparsentan 在 FSGS 患者中的疗效和安全性的 2 期研究。
J Am Soc Nephrol. 2018 Nov;29(11):2745-2754. doi: 10.1681/ASN.2018010091.
5
Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial.口服甲泼尼龙对IgA肾病患者临床结局的影响：TESTING随机临床试验
JAMA. 2017 Aug 1;318(5):432-442. doi: 10.1001/jama.2017.9362.
6
Treatment with Glucocorticoids or Calcineurin Inhibitors in Primary FSGS.原发性局灶节段性肾小球硬化症中糖皮质激素或钙调神经磷酸酶抑制剂的治疗
Clin J Am Soc Nephrol. 2016 Mar 7;11(3):386-94. doi: 10.2215/CJN.07110615. Epub 2016 Feb 16.
7
The Incidence of End-Stage Renal Disease in the Diabetic (Compared to the Non-Diabetic) Population: A Systematic Review.糖尿病（与非糖尿病相比）人群中终末期肾病的发病率：一项系统评价。
PLoS One. 2016 Jan 26;11(1):e0147329. doi: 10.1371/journal.pone.0147329. eCollection 2016.
8
Intensive Supportive Care plus Immunosuppression in IgA Nephropathy.IgA 肾病的强化支持治疗加免疫抑制。
N Engl J Med. 2015 Dec 3;373(23):2225-36. doi: 10.1056/NEJMoa1415463.
9
Non-diabetic renal disease (NDRD) in patients with type 2 diabetes mellitus (type 2 DM).2型糖尿病（2型DM）患者中的非糖尿病肾病（NDRD）。
J Assoc Physicians India. 2013 Mar;61(3):194-9.
10
The modern spectrum of renal biopsy findings in patients with diabetes.糖尿病患者肾活检的现代表现谱。
Clin J Am Soc Nephrol. 2013 Oct;8(10):1718-24. doi: 10.2215/CJN.02510213. Epub 2013 Jul 25.

Glomerular Diseases in Patients with Diabetes Mellitus: An Underappreciated Epidemic.

作者信息

Freeman Natasha S, Canetta Pietro A, Bomback Andrew S

机构信息

Division of Nephrology, Columbia University Roy and Diana Vagelos College of Physicians and Surgeons, New York, New York.

出版信息

Kidney360. 2020 Feb 6;1(3):220-222. doi: 10.34067/KID.0000792019. eCollection 2020 Mar 26.

DOI:10.34067/KID.0000792019
PMID:35368634
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8809255/
Abstract
摘要